COMPLEMENT ACTIVITY IN MIDDLE-EAR EFFUSIONS
- 1 January 1978
- journal article
- research article
- Vol. 33 (2), 340-346
Abstract
Evidence for complement utilization in middle ear fluids (MEF) from patients with otitis media with effusion was sought. Cleavage products of C[complement component]3, C4 and factor B could be demonstrated immunochemically in MEF, and native C3 was present in much lower concentrations than other proteins, relative to their serum concentrations. Hemolytic assays for C1-C5 showed that early complement components were inactivated in MEF. Potential mechanisms for complement utilization in MEF were discussed.This publication has 14 references indexed in Scilit:
- Cytologic and Immunologic Response Revealed in Middle Ear EffusionsAnnals of Otology, Rhinology & Laryngology, 1976
- Cleavage products of C4b produced by enzymes in human serumImmunochemistry, 1975
- Symposium on prophylaxis and treatment of middle ear effusions.: Iv. Physiology of the eustachian tube in the pathogenesis and management of middle ear effusionsThe Laryngoscope, 1972
- The "in vivo sensitivity test"--bacteriology of middle ear exudate, during antimicrobial therapy in otitis media.1969
- Pathology and Pathogenesis of Serous Otitis MediaJAMA Otolaryngology–Head & Neck Surgery, 1966
- Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serumImmunochemistry, 1966
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- Antigen-antibody crossed electrophoresisAnalytical Biochemistry, 1965
- LV Middle Ear Effusions: Pathologic Changes of the Mucoperiosteum in the Experimental AnimalAnnals of Otology, Rhinology & Laryngology, 1962